eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2009
vol. 34
 
Share:
Share:

Experimental immunology
The effect of Rhodiola rosea extracts on the bacterial infection in mice

Janusz Bany
,
Danuta Zdanowska
,
Ewa Skopińska-Różewska
,
Ewa Sommer
,
Andrzej K. Siwicki
,
Aleksander Wasiutyński

Centr Eur J Immunol 2009; 34 (1): 35-37
Online publish date: 2009/03/31
Article file
Get citation
 
 
Introduction
In people immunocompromised due to immunosuppressive treatment, cancer therapy, severe burns or other reasons, opportunistic infections are often seen [1-4]. Pseudomonas aeruginosa is one of the most frequently observed pathogens. Rhodiola rosea L. is a valuable medicinal herb known mainly as an adaptogen and anti-depressant. Its grows in Russia, Mongolia, China, Korea, Japan, Sakhalin, Kuriles, North America, Greenland and Europe [5]. In the previous studies performed in vitro in rats and pigs, we observed enhancement of intracellular respiratory burst and potential bactericidal activity in blood leukocyte cultures in the presence of R. rosea extracts [6]. In this study we observed the effect of feeding mice for 7 days R. rosea extracts on the subsequently induced bacterial infection in mice.

Material and Methods
Preparation of extracts
Rhodiola rosea (Crassulaceae) roots and rhizomes were cultivated, collected and identified in the Research Institute of Medicinal Plants (RIMP), Poznań, thanks to prof. Przemysław M. Mrozikiewicz and dr Waldemar Buchwald. Sample extractions and their chemical analysis were performed by the scientists from RIMP (Alina Mścisz, Anna Krajewska-Patan, Sebastian Mielcarek), and from Warsaw Medical University (Mirosława Furmanowa, Małgorzata Hartwich) as described before [6, 7]. Briefly: air-dried finely powdered roots were extracted two times with water (aqueous extract, RRW) or 50% ethanol (hydro-alcoholic extract, RRA), at 40-45°C, evaporated to dryness and lyophilized.
Animals
Studies were performed on B6C3F1 hybrid mice, males, at the age of 10-12 weeks, delivered from own breeding colony. All experiments were accepted by the local Ethical Committee.
Bacterial infection
Mice were fed R. rosea water extract (RRW) or hydro-alcoholic extract (RRA) 0.4 mg daily, in 10% ethyl alcohol, or 0.04 ml of 10% alcohol as a control, by Eppendorff pipette, for 7 days. On the day 8-ght mice were infected intraperitoneally (i.p.) with Pseudomonas aeruginosa strain ATCC (27 853). Four hours after administration of 0.1 ml of bacteria suspension (3 × 107 CFU) the mice were anaesthetized with barbiturates and killed by spinal dislocation after which the livers were isolated. The livers were homogenized and the number of viable bacteria were estimated by plating after 24 hours growth on Cetrymide agar (Merck) [8].
Statistical metods
The results were verified statistically by a one-way ANOVA analysis of variance and the significance of differences between the groups was verified with a Dunnett’s Multiple Comparison test (GraphPadPrism software package).

Results
The results are presented graphically on the Fig. 1.
A significantly decreased number of bacteria in livers of infected mice fed water extract of R. rosea was demonstrated in comparison to the control group. The weaker inhibitory effect of hydro-alcoholic extract was also statistically significant.

Discussion
Natural drugs, having immunostimulatory activity, may be a valuable complementation of the conventional anti-microbial treatment. In our previous studies, we observed stimulatory effect of Rhodiola rosea extracts on various parameters of non-specific and specific cellular immunity in mice, rats and pigs [6]. In this paper, we present evidence of the beneficial effect of Rhodiola rosea extracts (especially aqueous) on the bacterial infection in mice. This effect is probably connected with the ability of Rhodiola to stimulate various populations of immune cells, as was shown previously by us [6, 9, 10] and by others [11]. Rhodiola rosea is a plant traditionally consumed as a tea. A lot of articles have been published about its anti-stress and adaptogenic potential. Biologically active substances mainly found in plant rhizomes are salidroside, rosin, rosavin, rosarin, gallic and chlorogenic acids, and tyrosol [12, 13]. There are a few papers about direct anti-viral and anti-bacterial activity of Rhodiola extracts. Some compounds presented in vitro inhibitory activity against HCV NS3 serine protease – the most active were Epicatechin derivatives, present in Rhodiola kirilowii extracts. Salidroside was inactive in this test system [14]. However, other authors described in vitro and in vivo antiviral effects of salidroside isolated from Rhodiola rosea extract against coxsackievirus B3 [15]. Rhodiola rosea was also recognized as an inhibitor of HIV-1 protease [16]. Some compounds isolated from the roots of Rhodiola kirilowii (gallic acid and epigallocatechin gallate) exhibited in vitro inhibitory and bactericidal activities against mycobacterium tuberculosis [17]. It is noteworthy, that aqueous extract of Rhodiola rosea used in our present study contained three times more of gallic acid than hydro-alcoholic one [6]. Previously, we observed better stimulatory activity of aqueous extract of Rhodiola rosea than hydro-alcoholic one on cellular immunity (graft-versus-host reaction in mice) [6]. Accordingly, we also observed stronger inhibitory effect of aqueous than hydro-alcoholic extract on tumor-induced angiogenesis [7]. Whether or not these phenomena are connected with gallic acid, will be the matter of our further study.

References
1. Spencer RC (1996): Predominant pathogens found in the European prevalence of infection in intensive care study.
E J Clin Micr Inf Dis 15: 281-285.
2. Pruitt BA, McManus AT, Kim SH et al. (1997): Burn wound infections: current status. World J Surg 22: 135-145.
3. Griffith SJ, Nathan RK, Selender RK et al. (1989): The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital. J Inf Dis 160: 103-106.
4. Korvick JA, Marsh JW, Starlz TE et al. (1991): Pseudomonas aeruginosa bacteriemia in patients undergoing liver transplantation: an emerging problem. Surgery 109: 62-68.
5. Monograph Rhodiola rosea (2002): Altern Med Rev 7: 421-423.
6. Siwicki AK, Skopińska-Różewska E, Hartwich M et al. (2007): The influence of Rhodiola rosea extracts on non-specific and specific cellular immunity in pigs, rats and mice. Centr Eur
J Immunol 32: 84-91.
7. Skopińska-Różewska E, Hartwich M, Siwicki AK et al. (2008): The influence of Rhodiola rosea extracts and rosavin on cutaneous angiogenesis induced in mice after grafting of syngeneic tumor cells. Centr Eur J Immunol 33: 102-107.
8. Bany J, Skopińska-Różewska E, Chorostowska-Wynimko J
et al. (2004): The effect of complex herbal remedy on the angiogenic activity of L-1 sarcoma cells, L-1 sarcoma tumor growth and on the bacterial infection in mice. Centr Eur
J Immunol 29: 29-34.
9. Skopińska-Różewska E, Wójcik R, Siwicki AK et al. (2008): The effect of Rhodiola quadrifida extracts on cellular immunity in mice and rats. Pol J Vet Sci 11: 105-111.
10. Wójcik R, Siwicki AK, Skopińska-Różewska E et al. (2008): The in vitro influence of Rhodiola quadrifida extracts on non-specific cellular immunity in pigs. Centr Eur J Immunol 33: 193-196.
11. Seo WG, Pae HO, Oh GS et al. (2001): The aqueous extract of Rhodiola sachalinensis root enhances the expression of inducible nitric oxide synthase gene in RAW264.7 macrophages. J Ethnopharmacol 76: 119-123.
12. Ming DS, Hillhouse BJ, Guns ES et al. (2005): Bioactive compounds from Rhodiola rosea. Phytother Res 19: 740-743.
13. Furmanowa M, Hartwich M, Alfermann AW et al. (1999): Rosavin as a product of glycosylation by Rhodiola rosea cell cultures. Plant Cell Tissue and Organ Culture 56: 105-110.
14. Zuo G, Li Z, Chen L, Xu X (2007): Activity of compounds from Chinese herbal medicine Rhodiola kirilowii against HCV NS3 serine protease. Antiviral Res 76: 86-92.
15. Wang H, Ding Y, Zhou J et al. (2008): The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3. Phytomedicine [Epub ahead of print].
16. Min BS, Bae KH, Kim YH (1999): Screening of Korean plants against HIV type 1 protease. Phytother Res 13: 680-682.
17. Wong YC, Zhao M, Zong YY et al. (2008): Chemical constituents and anti-tuberculosis activity of root of Rhodiola kirilowii. Zhongguo Zhong Yao Za Zhi 33: 1561-1565.
Copyright: © 2009 Polish Society of Experimental and Clinical Immunology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.